News

As per the alliance, PolyPid will develop the new product, which will be based on BonyPid PolyPid’s product family, that can also treat specific dental problems requiring local,

Earlier to this appointment, Carnegie-Brown served as CEO of Evolutec, a biological drug development business, where he led a successful IPO and established the company’s clinical and manufacturing

The firm claims that the new combo also provides a natural approach to relieve menopause symptoms. The new supplement is created using the combination of slow-release technology with

Under the collaboration, Array will develop assays and screen its proprietary lead generation library of 300,000 small molecules to identify both active site and allosteric modulators of certain

Zoledronic Acid Injection (4 mg/5 mL) is generic bioequivalent to Novartis Oncology’s Zometa (zoledronic acid) injection in the same strength. Zometa is intended for use to prevent skeletal

Saladax is planning to use the equity investment fund to expand its product line and commercialize its existing MyCare products. The company’s MyCare blood tests target to optimize

According to the firm, the expansion, which aims to fulfil the growing needs of the European and Asia Pacific markets, will complement its existing dry powder media facility

The partnership, which intends to identify new drug combinations for solid tumor indications, will leverage Presage’s proprietary, patented drug array platform, which has the ability to simultaneously analyze

As part of the research collaboration, Riboxx will provide access to Riboxxim to enable CNBG to perform an evaluation, in conjunction with CNBG’s antigen, against the disease target.